Kestra Medical Technologies, Ltd. Common Stock

Kestra Medical Technologies, Ltd. Common Stock

KMTS · NASDAQ · Healthcare / Medical Instruments & Supplies

28.64USD+0.02 (+0.07%)

Price History

Full chart

Market Stats

Previous Close28.62
Open28.59
Day Range27.86 – 29.12
52-Week Range17.34 – 30.00
Volume343.35K
Market Cap1.68B
P/E (TTM)0.00
Forward P/E0.00
EPS-2.77
Dividend Yield0.00%
50-Day Avg25.27
200-Day Avg23.55

About

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clinical insights. The company also develops and commercializes Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. Its platform provides ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected; digital patient engagement and clinical workflow solutions designed to improve patient adherence, support care coordination, and provide actionable clinical insights throughout the recovery process; and integrated platform generates continuous cardiac rhythm data and clinically actionable insights. Kestra Medical Technologies, Ltd. was founded in 2014 and is based in Kirkland, Washington.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Brian Webster
  • Employees443
  • Headquarters3933 Lake Washington Blvd NE, Kirkland, WA, United States, 98033, USA
  • Websitehttps://kestramedical.com

Leadership

  • Mr. Brian WebsterFounder, President, CEO & Director · b. 1964
  • Ms. Traci S. UmbergerCo-Founder, General Counsel, Chief Administrative Officer, Secretary & Director · b. 1963
  • Mr. Vaseem MahboobChief Financial Officer · b. 1969
  • Mr. Gordon TeddyChief Information Officer
  • Mr. Alfred J. Ford Jr.Chief Commercial Officer · b. 1971
  • Mr. Neil BhalodkarVice President of Investor Relations
  • Ms. Debra SchotzSenior Vice President of Marketing · b. 1970
  • Mr. Jeffrey LaubSenior Vice President of Operations · b. 1971
  • Mr. Timothy P. MoranChief Business Officer · b. 1972
  • Mr. R. Curtis KopfSenior Vice President of Customer Experience · b. 1966

Financials

Income Statement

Currency: USD2020-04-302021-04-302023-04-302024-04-302025-04-302026-04-30
Total Revenue007.63M27.81M59.81M95.13M
Growth (%)---+264.53%+115.05%+59.04%
Cost of Revenue--18.28M27.45M35.60M46.26M
Gross Profit---10.65M362.00K24.21M48.86M
Gross Margin---139.59%1.30%40.47%51.37%
Operating Expense--69.77M85.42M130.59M183.60M
Operating Income-29.32M-32.71M-80.42M-85.06M-106.38M-134.74M
Operating Margin---1054.01%-305.83%-177.85%-141.64%
EBITDA-28.84M-32.33M-73.74M-76.31M-97.98M-150.04M
EBITDA Margin---966.44%-274.34%-163.80%-157.72%
Net Income-29.47M-34.10M-84.24M-94.12M-113.81M-131.61M
Net Income Margin---1104.04%-338.39%-190.28%-138.35%
R&D22.80M18.81M15.76M15.49M15.65M19.48M
R&D as % of Total Revenue--206.50%55.69%26.17%20.48%
Interest Expense01.17M5.63M6.23M7.73M7.55M
Interest Expense % of Total Revenue--73.77%22.40%12.93%7.93%

Balance Sheet

Currency: USD2020-04-302021-04-302023-04-302024-04-302025-04-302026-04-30
Total Assets7.87M30.52M38.66M45.95M295.74M358.46M
Total Liabilities4.02M28.76M156.23M255.33M90.34M98.81M
Total Equity3.86M1.77M-117.58M-209.38M205.41M259.66M
Cash5.76M24.34M14.81M8.25M237.59M99.71M
Total Debt452.00K22.85M39.13M45.17M44.31M46.79M
Net Debt-5.30M-1.49M24.32M36.92M-193.28M-52.92M

Cash Flow

Currency: USD2020-04-302021-04-302023-04-302024-04-302025-04-302026-04-30
Operating Cash Flow-30.29M-29.89M-69.64M-72.23M-77.61M-81.70M
Investing Cash Flow-232.00K-334.00K-15.46M-12.23M-23.31M-203.28M
Financing Cash Flow30.24M48.81M96.11M77.72M330.26M147.09M
Capital Expenditure232.00K336.00K15.46M12.51M23.59M34.89M
Free Cash Flow-30.52M-30.23M-85.10M-84.75M-101.20M-116.59M
Dividends Paid183.00K187.00K671.00K799.00K1.65M323.00K
FCF to OCF100.77%101.12%122.20%117.32%130.40%142.71%
Dividend Paid to FCF-0.60%-0.62%-0.79%-0.94%-1.63%-0.28%

Earnings

Report DateApr 14, 2025Jul 15, 2025Sep 11, 2025Dec 11, 2025Mar 17, 2026Jul 14, 2026Sep 14, 2026
EPS Estimate-0.64-0.53-0.78-0.56-0.60-0.59-0.61
EPS Actual-1.18-1.06-0.36-0.45-0.40-0.67-0.75
Surprise-84.38%-99.91%53.85%19.64%33.33%-13.56%-22.95%
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap1.68B
Enterprise Value1.40B
Trailing P/E0.00
Forward P/E0.00
Price / Sales15.70
Price / Book6.83
EPS-2.77
Book Value3.75
Revenue (TTM)106.73M
Gross Profit (TTM)57.51M
EBITDA-134.18M
Profit Margin-140.43%
Operating Margin-121.59%
Return on Equity-73.74%
Return on Assets-29.24%
Shares Outstanding59.56M
Shares Float33.70M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 6 analystsTarget 30.29
  • Strong Buy
    4
  • Buy
    1
  • Hold
    1

Ownership Breakdown

Institutions
101.65%
Insiders
5.26%
Retail / Other
0.00%

Top Institutional Holders

  • Bain Capital Investors LLC
    25.17M42.95%
  • T. Rowe Price Associates, Inc.
    5.97M10.18%
  • FMR Inc
    5.72M9.76%
  • Andera Partners
    2.73M4.66%
  • Yu Fan
    2.28M3.89%
  • Brown Advisory Holdings Inc
    1.72M2.94%
  • BlackRock Inc
    1.69M2.88%
  • Eventide Asset Management, LLC
    1.45M2.47%
  • AllianceBernstein L.P.
    1.32M2.25%
  • Franklin Templeton Inc
    1.24M2.12%
  • Vanguard Capital Management, LLC
    1.21M2.07%
  • Omega Fund Management LLC
    1.02M1.74%
  • State Street Corp
    671.11K1.15%

Top Fund Holders

  • T. Rowe Price New Horizons
    2.44M4.12%
  • Eventide Healthcare & Life Sciences I
    1.37M2.31%
  • Fidelity Select Health Care
    999.77K1.69%
  • Fidelity Select Medical Tech and Devcs
    999.03K1.69%
  • Vanguard MStar Total Stk Mkt Idx Invest
    927.19K1.56%
  • Franklin Small Cap Growth Adv
    775.11K1.31%
  • iShares Russell 2000 ETF
    682.75K1.15%